Biggest News Aggregation in the World
📰 Bio News

Page 115 - Bio News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bio. Real-time updates on events, politics, business and more.

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Metis Global Partners LLC

Metis Global Partners LLC lifted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 33.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 664 shares of the medical research company’s stock after buying an additional 166 shares during the quarter. […]
United States Timothys Ernst Royal Bank Metlife Investment Management Life Sciences Raymond James Trust

Bio-Rad Laboratories (NYSE:BIO) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Rating) issued its earnings results on Thursday. The medical research company reported $3.34 earnings per share for the quarter, topping the consensus estimate of $3.24 by $0.10, Briefing.com reports. Bio-Rad Laboratories had a positive return on equity of 4.19% and a negative net margin of 7.01%. The business had revenue […]
United States Timothys Ernst Raymond James Trust Credit Suisse Group Bio Rad Laboratories Company Profile Life Sciences

Bio-Rad Laboratories (NYSE:BIO) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Rating) released its quarterly earnings results on Thursday. The medical research company reported $3.34 earnings per share for the quarter, topping the consensus estimate of $3.24 by $0.10, Briefing.com reports. The business had revenue of $676.80 million for the quarter, compared to analysts’ expectations of $689.28 million. Bio-Rad Laboratories had […]
Timothys Ernst Invesco Ltd Credit Suisse Group Royal Bank Life Sciences Norges Bank
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Beats Estimates By $0.10 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Rating) announced its earnings results on Thursday. The medical research company reported $3.34 EPS for the quarter, topping analysts’ consensus estimates of $3.24 by $0.10, Briefing.com reports. Bio-Rad Laboratories had a positive return on equity of 4.59% and a negative net margin of 129.66%. The firm had revenue of $676.80 […]
Timothys Ernst Northwestern Mutual Wealth Management Co Life Sciences Truist Financial Corp Bio Rad Laboratories Company Profile Royal Bank

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science